ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 272 filers reported holding ALKERMES PLC in Q2 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,240,800 | -10.5% | 80,000 | 0.0% | 0.54% | -10.9% |
| Q2 2023 | $2,504,000 | +12.5% | 80,000 | 0.0% | 0.60% | +3.1% |
| Q1 2023 | $2,225,600 | +6.5% | 80,000 | 0.0% | 0.59% | +6.5% |
| Q4 2022 | $2,090,400 | +108.0% | 80,000 | +77.8% | 0.55% | +84.9% |
| Q3 2022 | $1,005,000 | -12.8% | 45,000 | 0.0% | 0.30% | +1.7% |
| Q2 2022 | $1,152,000 | -2.7% | 45,000 | 0.0% | 0.29% | +3.5% |
| Q1 2022 | $1,184,000 | +13.1% | 45,000 | 0.0% | 0.28% | -5.4% |
| Q4 2021 | $1,047,000 | -24.6% | 45,000 | 0.0% | 0.30% | -34.1% |
| Q3 2021 | $1,388,000 | +25.8% | 45,000 | 0.0% | 0.45% | +23.4% |
| Q2 2021 | $1,103,000 | +31.2% | 45,000 | 0.0% | 0.37% | +14.3% |
| Q1 2021 | $841,000 | -6.3% | 45,000 | 0.0% | 0.32% | -32.5% |
| Q4 2020 | $898,000 | +116.9% | 45,000 | +80.0% | 0.48% | +85.6% |
| Q3 2020 | $414,000 | – | 25,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |